HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Is ASL Marine Shifting From Surviving To Thriving?

When most investors think about a thriving marine company, they picture massive shipyards launching...
SGX-LISTED COMPANIES

Is Soon Hock’s Strategy Future-Ready?

Introduction: When you think of industrial real estate, the image that often comes to mind...
SGX-LISTED COMPANIES

Totm Technologies HY 2025 Revenue Collapse & Web3 Gamble

At first glance, TOTM Technologies' latest interim report flashes red flags. Revenue is down...
SGX-LISTED COMPANIES

GKE Corporation 1H FY26 Profit Crash & S$120M Dubai Expansion Gamble

GKE's S$120M Global Play: Why the "Gestation Period" is a Growth Story in Disguise In...
SGX-LISTED COMPANIES

How HC Surgical Specialists Boosted Profits Despite A Revenue Dip In HY FY2026

Precision in the Markets In the business of medicine, conventional wisdom suggests that if your...
SGX-LISTED COMPANIES

Duty Free International Abandons Retail For Automotive Pivot In Q3 2025

The Great Malaysian Pivot: How Duty Free International is Trading Perfume for Pistons Numbers Never...
SGX-LISTED COMPANIES

Why Singapore’s $44 Billion Construction Boom Starts With This Under-the-Radar Powerhouse

Investing in the Foundations If you live in Singapore, your daily commute is likely a...
SGX-LISTED COMPANIES

Why NTT DC REIT Is The Lucrative Infrastructure Play For The Robotics Revolution

The AI Brain in Brick and Mortar Introduction: The Physicality of the Digital Cloud Investors often...
SGX-LISTED COMPANIES

How Shopper360 Turned Massive Losses Into Profit In 1H2026

From Red to Black: 4 Surprising Takeaways from shopper360’s Strategic Rebound 1. The Art of...
SGX-LISTED COMPANIES

Is PC Partner The Most Undervalued Way To Ride The NVIDIA Wave?

From China to Singapore: The AI Boom's Hidden Backdoor For the modern investor, the "NVIDIA...
SGX-LISTED COMPANIES

Police Reports Filed After CEO Sacked Amid Corporate Scandal – Advanced Systems Automation HY2025

5 Shocking Takeaways from ASA’s HY2025 Report Financial reports are typically dry exercises in accounting,...
SGX-LISTED COMPANIES

500% Profit Surge – How Fortress Minerals Is Defying Global Steel Headwinds In Q3 FY2026

The global steel industry is currently navigating a period of significant contraction. Between January...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...